64Cu-ATSM/64Cu-Cl2 and their relationship to hypoxia in glioblastoma: a preclinical study.

Abstract:

BACKGROUND:Diacetyl-bis(N4-methylthiosemicarbazone), labeled with 64Cu (64Cu-ATSM) has been suggested as a promising tracer for imaging hypoxia. However, various controversial studies highlighted potential pitfalls that may disable its use as a selective hypoxic marker. They also highlighted that the results may be tumor location dependent. Here, we first analyzed uptake of Cu-ATSM and its less lipophilic counterpart Cu-Cl2 in the tumor over time in an orthotopic glioblastoma model. An in vitro study was also conducted to investigate the hypoxia-dependent copper uptake in tumor cells. We then further performed a comprehensive ex vivo study to compare 64Cu uptake to hypoxic markers, specific cellular reactions, and also transporter expression. METHODS:μPET was performed 14 days (18F-FMISO), 15 days (64Cu-ATSM and 64Cu-Cl2), and 16 days (64Cu-ATSM and 64Cu-Cl2) after C6 cell inoculation. Thereafter, the brains were withdrawn for further autoradiography and immunohistochemistry. C6 cells were also grown in hypoxic workstation to analyze cellular uptake of Cu complexes in different oxygen levels. RESULTS:In vivo results showed that Cu-ASTM and Cu-Cl2 accumulated in hypoxic areas of the tumors. Cu-ATSM also stained, to a lesser extent, non-hypoxic regions, such as regions of astrogliosis, with high expression of copper transporters and in particular DMT-1 and CTR1, and also characterized by the expression of elevated astrogliosis. In vitro results show that 64Cu-ATSM showed an increase in the uptake only in severe hypoxia at 0.5 and 0.2% of oxygen while for 64Cu-Cl2, the cell retention was significantly increased at 5% and 1% of oxygen with no significant rise at lower oxygen percentages. CONCLUSION:In the present study, we show that Cu-complexes undoubtedly accumulate in hypoxic areas of the tumors. This uptake may be the reflection of a direct dependency to a redox metabolism and also a reflection of hypoxic-induced overexpression of transporters. We also show that Cu-ATSM also stained non-hypoxic regions such as astrogliosis.

journal_name

EJNMMI Res

journal_title

EJNMMI research

authors

Pérès EA,Toutain J,Paty LP,Divoux D,Ibazizène M,Guillouet S,Barré L,Vidal A,Cherel M,Bourgeois M,Bernaudin M,Valable S

doi

10.1186/s13550-019-0586-6

subject

Has Abstract

pub_date

2019-12-19 00:00:00

pages

114

issue

1

issn

2191-219X

pii

10.1186/s13550-019-0586-6

journal_volume

9

pub_type

杂志文章
  • Diagnostic value of PET/CT with 11C-methionine (MET) and 18F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification.

    abstract:BACKGROUND:The molecular features of isocitrate dehydrogenase (IDH) mutation and chromosome 1p and 19q (1p/19q) codeletion status have pivotal role for differentiating gliomas and have been integrated in the World Health Organization (WHO) classification in 2016. Positron emission tomography (PET) with 3'-deoxy-3'-[18F...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-00633-1

    authors: Ogawa T,Kawai N,Miyake K,Shinomiya A,Yamamoto Y,Nishiyama Y,Tamiya T

    更新日期:2020-05-07 00:00:00

  • Peptide receptor radionuclide therapy (PRRT) with [(177)Lu-DOTA(0),Tyr(3)]octreotate in combination with RAD001 treatment: further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model.

    abstract:BACKGROUND:Previously, we reported on the unexpected development of distant metastases in the subcutaneous rat pancreas CA20948 tumor model after 4.5 weeks of treatment with RAD001-only or in combination with [(177)Lu-DOTA(0),Tyr(3)]octreotate ((177)Lu-DOTATATE) (Cancer Res. 73:12-8, 2013). Moreover, the combination th...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-014-0021-y

    authors: Bison SM,Pool SE,Koelewijn SJ,van der Graaf LM,Groen HC,Melis M,de Jong M

    更新日期:2014-05-30 00:00:00

  • Evaluation of retinol binding protein 4 and carbamoylated haemoglobin as potential renal toxicity biomarkers in adult mice treated with (177)Lu-octreotate.

    abstract:BACKGROUND:The kidneys are regarded as one of the main dose-limiting organs in the treatment of neuroendocrine tumours with (177)Lu-[DOTA(0), Tyr(3)]-octreotate ((177)Lu-octreotate), despite the successful use of kidney uptake blocking agents such as lysine and arginine. To avoid renal toxicity but still give each pati...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-014-0059-x

    authors: Dalmo J,Westberg E,Barregard L,Svedbom L,Johansson M,Törnqvist M,Forssell-Aronsson E

    更新日期:2014-12-01 00:00:00

  • Metabolic liver function in humans measured by 2-18F-fluoro-2-deoxy-D-galactose PET/CT-reproducibility and clinical potential.

    abstract:BACKGROUND:PET/CT with the radioactively labelled galactose analogue 2-18F-fluoro-2-deoxy-D-galactose (18F-FDGal) can be used to quantify the hepatic metabolic function and visualise regional metabolic heterogeneity. We determined the day-to-day variation in humans with and without liver disease. Furthermore, we examin...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-017-0320-1

    authors: Bak-Fredslund KP,Lykke Eriksen P,Munk OL,Villadsen GE,Keiding S,Sørensen M

    更新日期:2017-08-29 00:00:00

  • 68Ga-PSMA PET/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with 177Lu-PSMA-617.

    abstract:BACKGROUND:Differentiated thyroid carcinoma (DTC) is the most common type of thyroid cancer. Treatment with surgery, radioactive iodine (RAI), and TSH suppression is effective in most patients. Five to 15% of patients become RAI refractory and need alternative therapy; however, treatment options are limited. 68Ga-PSMA ...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-0610-x

    authors: de Vries LH,Lodewijk L,Braat AJAT,Krijger GC,Valk GD,Lam MGEH,Borel Rinkes IHM,Vriens MR,de Keizer B

    更新日期:2020-03-06 00:00:00

  • Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer.

    abstract:BACKGROUND:Hypoxic tumours exhibit increased resistance to radiation, chemical, and immune therapies. 18F-fluoromisonidazole (FMISO) positron emission tomography (PET) is a non-invasive, quantitative imaging technique used to evaluate the presence and spatial distribution of tumour hypoxia. To facilitate the use of FMI...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-016-0210-y

    authors: Grkovski M,Schwartz J,Rimner A,Schöder H,Carlin SD,Zanzonico PB,Humm JL,Nehmeh SA

    更新日期:2016-12-01 00:00:00

  • The effect of isoflurane on 18F-FDG uptake in the rat brain: a fully conscious dynamic PET study using motion compensation.

    abstract:BACKGROUND:In preclinical positron emission tomography (PET) studies an anaesthetic is used to ensure that the animal does not move during the scan. However, anaesthesia may have confounding effects on the drug or tracer kinetics under study, and the nature of these effects is usually not known. METHOD:We have impleme...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-016-0242-3

    authors: Spangler-Bickell MG,de Laat B,Fulton R,Bormans G,Nuyts J

    更新日期:2016-12-01 00:00:00

  • 99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry study.

    abstract:BACKGROUND:Biologicals directed against tumour necrosis factor (TNF) have proven their efficacy in the treatment of spondyloarthritis and rheumatoid arthritis. We present a radiolabelling method for certolizumab pegol (CZP), a commercially available humanized Fab'-fragment directed against TNF. A biodistribution and do...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-016-0245-0

    authors: Lambert B,Carron P,D'Asseler Y,Bacher K,Van den Bosch F,Elewaut D,Verbruggen G,Beyaert R,Dumolyn C,De Vos F

    更新日期:2016-12-01 00:00:00

  • Labeling of DOTA-conjugated HPMA-based polymers with trivalent metallic radionuclides for molecular imaging.

    abstract:BACKGROUND:In this work, the in vitro and in vivo stabilities and the pharmacology of HPMA-made homopolymers were studied by means of radiometal-labeled derivatives. Aiming to identify the fewer amount and the optimal DOTA-linker structure that provides quantitative labeling yields, diverse DOTA-linker systems were con...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-018-0372-x

    authors: Eppard E,de la Fuente A,Mohr N,Allmeroth M,Zentel R,Miederer M,Pektor S,Rösch F

    更新日期:2018-02-27 00:00:00

  • Reflections on the theory of "silver bullet" octreotide tracers: implications for ligand-receptor interactions in the age of peptides, heterodimers, receptor mosaics, truncated receptors, and multifractal analysis.

    abstract:: The classical attitude of Nuclear Medicine practitioners on matters of peptide-receptor interactions has maintained an intrinsic monogamic character since many years. New advances in the field of biochemistry and even in clinical Nuclear Medicine have challenged this type of thinking, which prompted me to work on thi...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-1-9

    authors: Moncayo R

    更新日期:2011-07-26 00:00:00

  • Imaging of the appearance time of cerebral blood using [15O]H2O PET for the computation of correct CBF.

    abstract:BACKGROUND:Quantification of cerebral blood flow (CBF) is important for the understanding of normal and pathologic brain physiology. Positron emission tomography (PET) with H215O (or C15O2) can quantify CBF and apply kinetic analyses, including autoradiography (ARG) and the basis function methods (BFM). These approache...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-3-41

    authors: Kudomi N,Maeda Y,Sasakawa Y,Monden T,Yamamoto Y,Kawai N,Iida H,Nishiyama Y

    更新日期:2013-05-23 00:00:00

  • Optimal MRI sequences for 68Ga-PSMA-11 PET/MRI in evaluation of biochemically recurrent prostate cancer.

    abstract:BACKGROUND:PET/MRI can be used for the detection of disease in biochemical recurrence (BCR) patients imaged with 68Ga-PSMA-11 PET. This study was designed to determine the optimal MRI sequences to localize positive findings on 68Ga-PSMA-11 PET of patients with BCR after definitive therapy. Fifty-five consecutive prosta...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-017-0327-7

    authors: Lake ST,Greene KL,Westphalen AC,Behr SC,Zagoria R,Small EJ,Carroll PR,Hope TA

    更新日期:2017-09-19 00:00:00

  • Nanobody: a promising toolkit for molecular imaging and disease therapy.

    abstract::Nanobodies are the recombinant variable domains of heavy-chain-only antibodies, with many unique properties such as small size, excellent solubility, superior stability, quick clearance from blood, and deep tissue penetration. As a result, nanobodies have become a promising tool for the diagnosis and therapy of diseas...

    journal_title:EJNMMI research

    pub_type: 杂志文章,评审

    doi:10.1186/s13550-021-00750-5

    authors: Bao G,Tang M,Zhao J,Zhu X

    更新日期:2021-01-19 00:00:00

  • Advanced brain dopamine transporter imaging in mice using small-animal SPECT/CT.

    abstract:UNLABELLED: BACKGROUND:Iodine-123-β-CIT, a single-photon emission computed tomography (SPECT) ligand for dopamine transporters (DATs), has been used for in vivo studies in humans, monkeys, and rats but has not yet been used extensively in mice. To validate the imaging and analysis methods for preclinical DAT imaging, ...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-2-55

    authors: Pitkonen M,Hippeläinen E,Raki M,Andressoo JO,Urtti A,Männistö PT,Savolainen S,Saarma M,Bergström K

    更新日期:2012-09-29 00:00:00

  • Short-term discontinuation of vagal nerve stimulation alters 18F-FDG blood pool activity: an exploratory interventional study in epilepsy patients.

    abstract:BACKGROUND:Vagus nerve activation impacts inflammation. Therefore, we hypothesized that vagal nerve stimulation (VNS) influenced arterial wall inflammation as measured by 18F-FDG uptake. RESULTS:Ten patients with left-sided VNS for refractory epilepsy were studied during stimulation (VNS-on) and in the hours after sti...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-019-0567-9

    authors: Boswijk E,Franssen R,Vijgen GHEJ,Wierts R,van der Pol JAJ,Mingels AMA,Cornips EMJ,Majoie MHJM,van Marken Lichtenbelt WD,Mottaghy FM,Wildberger JE,Bucerius J

    更新日期:2019-11-27 00:00:00

  • Comparison of LDPI to SPECT perfusion imaging using (99m)Tc-sestamibi and (99m)Tc-pyrophosphate in a murine ischemic hind limb model of neovascularization.

    abstract:BACKGROUND:We aimed to determine the accuracy of laser Doppler perfusion imaging (LDPI) in an animal model for hind limb ischemia. METHODS:We used a murine (C57Bl/6 mice) ischemic hind limb model in which we compared LDPI with the clinically used (99m)Tc-sestamibi SPECT perfusion imaging (n = 7). In addition, we used ...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-016-0199-2

    authors: Hendrikx G,Vries MH,Bauwens M,De Saint-Hubert M,Wagenaar A,Guillaume J,Boonen L,Post MJ,Mottaghy FM

    更新日期:2016-12-01 00:00:00

  • 18F-FDG and 68Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study.

    abstract:BACKGROUND:Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin tumor. Currently, 18F-fluoro-deoxy-glucose (18F-FDG) PET/CT is the functional imaging modality of choice. Few data are available on the use of 68Ga-somatostatin analogs. The aim of our study was to evaluate and compare the diagnostic performanc...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-018-0423-3

    authors: Taralli S,Sollini M,Milella M,Perotti G,Filice A,Menga M,Versari A,Rufini V

    更新日期:2018-07-21 00:00:00

  • A comparative 18F-FDG PET/CT imaging of experimental Staphylococcus aureus osteomyelitis and Staphylococcus epidermidis foreign-body-associated infection in the rabbit tibia.

    abstract:BACKGROUND:18F-FDG-PET imaging has emerged as a promising method in the diagnosis of chronic osteomyelitis commonly due to Staphylococcus aureus. The inaccuracy of 18 F-FDG-PET in the detection of periprosthetic joint infections may be related to the predominance of low-virulent S. epidermidis strains as the causative ...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-2-41

    authors: Lankinen P,Lehtimäki K,Hakanen AJ,Roivainen A,Aro HT

    更新日期:2012-07-23 00:00:00

  • Targeted beta therapy of prostate cancer with 177Lu-labelled Miltuximab® antibody against glypican-1 (GPC-1).

    abstract:PURPOSE:Chimeric antibody Miltuximab®, a human IgG1 engineered from the parent antibody MIL-38, is in clinical development for solid tumour therapy. Miltuximab® targets glypican-1 (GPC-1), a cell surface protein involved in tumour growth, which is overexpressed in solid tumours, including prostate cancer (PCa). This st...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-00637-x

    authors: Yeh MC,Tse BWC,Fletcher NL,Houston ZH,Lund M,Volpert M,Stewart C,Sokolowski KA,Jeet V,Thurecht KJ,Campbell DH,Walsh BJ,Nelson CC,Russell PJ

    更新日期:2020-05-07 00:00:00

  • Correction to: Neurologically asymptomatic cerebral oligometastatic prostate carcinoma metastasis identified on [Ga]Ga-THP-PSMA PET/CT.

    abstract::An amendment to this paper has been published and can be accessed via the original article. ...

    journal_title:EJNMMI research

    pub_type: 已发布勘误

    doi:10.1186/s13550-020-00719-w

    authors: Ross MI,Bird N,Mendichovszky IA,Rimmer YL

    更新日期:2020-10-27 00:00:00

  • Kinetic modeling of 68Ga-PSMA-11 and validation of simplified methods for quantification in primary prostate cancer patients.

    abstract:BACKGROUND:The positron emission tomography (PET) ligand 68Ga-Glu-urea-Lys(Ahx)-HBED-CC (68Ga-PSMA-11) targets the prostate-specific membrane antigen (PSMA), upregulated in prostate cancer cells. Although 68Ga-PSMA-11 PET is widely used in research and clinical practice, full kinetic modeling has not yet been reported ...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-0594-6

    authors: Ringheim A,Campos Neto GC,Anazodo U,Cui L,da Cunha ML,Vitor T,Martins KM,Miranda ACC,de Barboza MF,Fuscaldi LL,Lemos GC,Colombo Junior JR,Baroni RH

    更新日期:2020-02-24 00:00:00

  • Multi-modal image analysis for semi-automatic segmentation of the total liver and liver arterial perfusion territories for radioembolization.

    abstract:PURPOSE:We have developed a multi-modal imaging approach for SIRT, combining 99mTc-MAA SPECT/CT and/or 90Y PET, 18F-FDG PET/CT, and contrast-enhanced CBCT for voxel-based dosimetry, as a tool for treatment planning and verification. For radiation dose prediction calculations, a segmentation of the total liver volume an...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-019-0485-x

    authors: Jafargholi Rangraz E,Coudyzer W,Maleux G,Baete K,Deroose CM,Nuyts J

    更新日期:2019-02-20 00:00:00

  • SPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy.

    abstract:BACKGROUND:Dosimetry in radionuclide therapy has the potential to allow for a treatment tailored to the individual patient. One therapeutic radiopharmaceutical where patient-specific dosimetry is feasible is 177Lu-DOTATATE, used for the treatment of neuroendocrine tumours. The emission of gamma photons by 177Lu allows ...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-017-0262-7

    authors: Gustafsson J,Sundlöv A,Sjögreen Gleisner K

    更新日期:2017-12-01 00:00:00

  • Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis.

    abstract:BACKGROUND:F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a promising modality for detecting active lesions of cardiac sarcoidosis (CS). However, determining whether 18F-FDG uptake in the myocardium is physiological is challenging due to metabolic shift in myocardial cells. Although methods for inhibi...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-4-1

    authors: Morooka M,Moroi M,Uno K,Ito K,Wu J,Nakagawa T,Kubota K,Minamimoto R,Miyata Y,Okasaki M,Okazaki O,Yamada Y,Yamaguchi T,Hiroe M

    更新日期:2014-01-02 00:00:00

  • Effects of common anesthetic agents on [18F]flumazenil binding to the GABAA receptor.

    abstract:BACKGROUND:The availability of GABAA receptor binding sites in the brain can be assessed by positron emission tomography (PET) using the radioligand, [18F]flumazenil. However, the brain uptake and binding of this PET radioligand are influenced by anesthetic drugs, which are typically needed in preclinical imaging studi...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-016-0235-2

    authors: Palner M,Beinat C,Banister S,Zanderigo F,Park JH,Shen B,Hjoernevik T,Jung JH,Lee BC,Kim SE,Fung L,Chin FT

    更新日期:2016-12-01 00:00:00

  • Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patients.

    abstract:BACKGROUND:Routine work-up for transarterial radioembolization, based on clinical and laboratory parameters, sometimes fails, resulting in severe hepatotoxicity in up to 5% of patients. Quantitative assessment of the pretreatment liver function and its segmental distribution, using hepatobiliary scintigraphy may improv...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-016-0248-x

    authors: Braat MNGJA,de Jong HW,Seinstra BA,Scholten MV,van den Bosch MAAJ,Lam MGEH

    更新日期:2017-12-01 00:00:00

  • Priming increases the anti-tumor effect and therapeutic window of 177Lu-octreotate in nude mice bearing human small intestine neuroendocrine tumor GOT1.

    abstract:BACKGROUND:177Lu-[DOTA0, Tyr3]-octreotate (177Lu-octreotate) is used for treatment of patients with somatostatin receptor (SSTR) expressing neuroendocrine tumors. However, complete tumor remission is rarely seen, and optimization of treatment protocols is needed. In vitro studies have shown that irradiation can up-regu...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-016-0247-y

    authors: Dalmo J,Spetz J,Montelius M,Langen B,Arvidsson Y,Johansson H,Parris TZ,Helou K,Wängberg B,Nilsson O,Ljungberg M,Forssell-Aronsson E

    更新日期:2017-12-01 00:00:00

  • Pilot study of PET imaging of 124I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancer.

    abstract:BACKGROUND:Hypoxia within solid tumors confers radiation resistance and a poorer prognosis. 124I-iodoazomycin galactopyranoside (124I-IAZGP) has shown promise as a hypoxia radiotracer in animal models. We performed a clinical study to evaluate the safety, biodistribution, and imaging characteristics of 124I-IAZGP in pa...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/2191-219X-3-42

    authors: O'Donoghue JA,Guillem JG,Schöder H,Lee NY,Divgi CR,Ruby JA,Humm JL,Lee-Kong SA,Burnazi EM,Cai S,Carlin SD,Leibold T,Zanzonico PB,Ling CC

    更新日期:2013-06-03 00:00:00

  • A new 68Ga-labeled somatostatin analog containing two iodo-amino acids for dual somatostatin receptor subtype 2 and 5 targeting.

    abstract:BACKGROUND:Somatostatin receptor (SST) targeting, specifically of the subtype 2 (SST2), with radiolabeled somatostatin analogs, is established for imaging and treatment of neuroendocrine tumors. Owing to the concomitant and heterogeneous expression of several subtypes on the same tumor, analogs targeting more subtypes ...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-00677-3

    authors: Mansi R,Abid K,Nicolas GP,Del Pozzo L,Grouzmann E,Fani M

    更新日期:2020-08-05 00:00:00

  • Interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer.

    abstract:BACKGROUND:Prostate-specific membrane antigen (PSMA) ligand PET/CT has already provided promising results in prostate cancer (PC) imaging, yet simple and reproductible reporting criteria are still lacking. This study aimed at retrospectively evaluating interobserver agreement of [68Ga]Ga-PSMA-11 PET/CT images interpret...

    journal_title:EJNMMI research

    pub_type: 杂志文章

    doi:10.1186/s13550-020-0596-4

    authors: Derwael C,Lavergne O,Lovinfosse P,Nechifor V,Salvé M,Waltregny D,Hustinx R,Withofs N

    更新日期:2020-02-28 00:00:00